Celgene
NASDAQ: CELG
$108.24
+$0.00 (+0.0%)
Closing Price on November 22, 2019
CELG Articles
The following are some of the top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and volume analysis...
Published:
Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early afternoon Thursday after Japan okayed one of the company’s human growth hormones, the first approval...
Published:
We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend. This is broken down...
Published:
It is actually looking pretty thin out there in the land of analyst upgrades. These are the few upgrades and positive research calls we have seen from Wall Street this Wednesday morning with about...
Published:
Last Updated:
This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association for Cancer Research Meeting will actually have a 100th annual...
Published:
These are ten of the top pre-market analyst calls for upgrades and downgrades we have seen from Wall Street this Wednesday morning with more than two hours until the market opens: Capital One (COF)...
Published:
Last Updated:
Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning. What many investors probably want to know is if these results — or more importantly its guidance — show that this...
Published:
Last Updated:
There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT reported that the world’s largest pharmaceutical company is willing to...
Published:
Last Updated:
It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally you see a pattern. This month the only pattern seems to be one...
Published:
These are some of the many research upgrades we have seen from Wall Street analysts this Monday morning with more than two hours to the open: Ann Taylor (ANN) Raised to Neutral at Goldman Sachs...
Published:
Short sellers moved out of biotech stocks in the latest period according to Biohealth Investor. The short interest in Amgen (AMGN) dropped 22% and Calgene (CELG) fell 20%. 100 Million Americans Are...
Published:
Last Updated:
We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and other companies involved in various aspects of health care and medicine. ...
Published:
One key stock to watch next week is Pfizer Inc. (NYSE: PFE). While it has been in the land of the boring forever, watchers are looking to see if it will put in a rival bid over the $4.6 Billion...
Published:
Below are some of the top issues affecting biotech shares today: AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company developing iron compounds to treat anemia, saw shares rise 4%...
Published:
Acorda Therapeutics inc. (NASDAQ: ACOR) showed late stage trial results on its drug candidate Fampridine-SR for treating multiple sclerosis. This data showed that Fampridine, which is designed to...
Published: